Carroll J - Search Results

1

Discovery of naturally occurring ESR1 mutations in breast cancer cell lines modelling endocrine resistance.

Martin LA, Ribas R, Simigdala N, Schuster E, Pancholi S, Tenev T, Gellert P, Buluwela L, Harrod A, Thornhill A, Nikitorowicz-Buniak J, Bhamra A, Turgeon MO, Poulogiannis G, Gao Q, Martins V, Hills M, Garcia-Murillas I, Fribbens C, Patani N, Li Z, Sikora MJ, Turner N, Zwart W, Oesterreich S, Carroll J, Ali S, Dowsett M. Martin LA, et al. Among authors: carroll j. Nat Commun. 2017 Nov 30;8(1):1865. doi: 10.1038/s41467-017-01864-y. Nat Commun. 2017. PMID: 29192207 Free PMC article.

2

Regulation of ERBB2 by oestrogen receptor-PAX2 determines response to tamoxifen.

Hurtado A, Holmes KA, Geistlinger TR, Hutcheson IR, Nicholson RI, Brown M, Jiang J, Howat WJ, Ali S, Carroll JS. Hurtado A, et al. Among authors: carroll js. Nature. 2008 Dec 4;456(7222):663-6. doi: 10.1038/nature07483. Epub 2008 Nov 12. Nature. 2008. PMID: 19005469 Free PMC article.

3

The liver receptor homolog-1 regulates estrogen receptor expression in breast cancer cells.

Thiruchelvam PT, Lai CF, Hua H, Thomas RS, Hurtado A, Hudson W, Bayly AR, Kyle FJ, Periyasamy M, Photiou A, Spivey AC, Ortlund EA, Whitby RJ, Carroll JS, Coombes RC, Buluwela L, Ali S. Thiruchelvam PT, et al. Among authors: carroll js. Breast Cancer Res Treat. 2011 Jun;127(2):385-96. doi: 10.1007/s10549-010-0994-9. Epub 2010 Jul 6. Breast Cancer Res Treat. 2011. PMID: 20607599

4

FOXA1 is a key determinant of estrogen receptor function and endocrine response.

Hurtado A, Holmes KA, Ross-Innes CS, Schmidt D, Carroll JS. Hurtado A, et al. Nat Genet. 2011 Jan;43(1):27-33. doi: 10.1038/ng.730. Epub 2010 Dec 12. Nat Genet. 2011. PMID: 21151129 Free PMC article.

5

Estrogen receptor-positive breast cancer: a multidisciplinary challenge.

Zwart W, Theodorou V, Carroll JS. Zwart W, et al. Wiley Interdiscip Rev Syst Biol Med. 2011 Mar-Apr;3(2):216-30. doi: 10.1002/wsbm.109. Wiley Interdiscip Rev Syst Biol Med. 2011. PMID: 21305704 Review.

6

A diagnostic gene profile for molecular subtyping of breast cancer associated with treatment response.

Krijgsman O, Roepman P, Zwart W, Carroll JS, Tian S, de Snoo FA, Bender RA, Bernards R, Glas AM. Krijgsman O, et al. Breast Cancer Res Treat. 2012 May;133(1):37-47. doi: 10.1007/s10549-011-1683-z. Epub 2011 Aug 4. Breast Cancer Res Treat. 2012. PMID: 21814749

7

Oestrogen receptor-co-factor-chromatin specificity in the transcriptional regulation of breast cancer.

Zwart W, Theodorou V, Kok M, Canisius S, Linn S, Carroll JS. Zwart W, et al. EMBO J. 2011 Oct 14;30(23):4764-76. doi: 10.1038/emboj.2011.368. EMBO J. 2011. PMID: 22002538 Free PMC article.

8

Differential oestrogen receptor binding is associated with clinical outcome in breast cancer.

Ross-Innes CS, Stark R, Teschendorff AE, Holmes KA, Ali HR, Dunning MJ, Brown GD, Gojis O, Ellis IO, Green AR, Ali S, Chin SF, Palmieri C, Caldas C, Carroll JS. Ross-Innes CS, et al. Among authors: carroll js. Nature. 2012 Jan 4;481(7381):389-93. doi: 10.1038/nature10730. Nature. 2012. PMID: 22217937 Free PMC article.

9

Pioneer factors in hormone-dependent cancers.

Jozwik KM, Carroll JS. Jozwik KM, et al. Nat Rev Cancer. 2012 May 4;12(6):381-5. doi: 10.1038/nrc3263. Nat Rev Cancer. 2012. PMID: 22555282 Review.

10

FOXA1 and breast cancer risk.

Meyer KB, Carroll JS. Meyer KB, et al. Nat Genet. 2012 Nov;44(11):1176-7. doi: 10.1038/ng.2449. Nat Genet. 2012. PMID: 23104063

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3,702 results

Search Page

Filters